Navalign LLC’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
10,076
-1,174
| -10% | -$126K | 0.3% | 58 |
|
|
2025
Q1 | $1.13M | Sell |
11,250
-543
| -5% | -$54.8K | 0.32% | 54 |
|
|
2024
Q4 | $1.05M | Sell |
11,793
-251
| -2% | -$22.4K | 0.31% | 55 |
|
|
2024
Q3 | $1.01M | Sell |
12,044
-385
| -3% | -$32.3K | 0.3% | 56 |
|
|
2024
Q2 | $957K | Sell |
12,429
-20
| -0.2% | -$1.54K | 0.3% | 55 |
|
|
2024
Q1 | $853K | Sell |
12,449
-374
| -3% | -$25.6K | 0.28% | 64 |
|
|
2023
Q4 | $741K | Sell |
12,823
-292
| -2% | -$16.9K | 0.26% | 71 |
|
|
2023
Q3 | $692K | Sell |
13,115
-490
| -4% | -$25.9K | 0.26% | 79 |
|
|
2023
Q2 | $736K | Sell |
13,605
-714
| -5% | -$38.6K | 0.29% | 64 |
|
|
2023
Q1 | $716K | Sell |
14,319
-289
| -2% | -$14.5K | 0.3% | 68 |
|
|
2022
Q4 | $676K | Sell |
14,608
-802
| -5% | -$37.1K | 0.28% | 77 |
|
|
2022
Q3 | $597K | Buy |
15,410
+616
| +4% | +$23.9K | 0.27% | 78 |
|
|
2022
Q2 | $551K | Sell |
14,794
-24
| -0.2% | -$894 | 0.24% | 78 |
|
|
2022
Q1 | $638K | Buy |
14,818
+571
| +4% | +$24.6K | 0.27% | 74 |
|
|
2021
Q4 | $605K | Buy |
14,247
+227
| +2% | +$9.64K | 0.24% | 87 |
|
|
2021
Q3 | $608K | Sell |
14,020
-31
| -0.2% | -$1.34K | 0.26% | 85 |
|
|
2021
Q2 | $601K | Buy |
14,051
+938
| +7% | +$40.1K | 0.25% | 82 |
|
|
2021
Q1 | $507K | Buy |
+13,113
| New | +$507K | 0.22% | 91 |
|